Abstract
Five volumes of the Neuropsychopharmacology: The Next Generation of Progress were published in print by the American College of Neuropsychopharmacology between the years 1968 and 2002. These volumes historically defined the scientific arena of neuropsychopharmacology and served for 40+ years as major references, providing a foundation of the research and therapeutics knowledge in psychiatric and neurological disorders. With the increasingly fast-paced evolution of our field, the ACNP opted to continue the tradition in the more dynamic format of devoting the first issue of its flagship journal each year to Neuropsychopharmacology Reviews: The Next Generation of Progress. The first six issues have provided outstanding and timely overviews of neuroplasticity (Vol. 1), central nervous system (CNS) drug discovery and development (Vol. 2), neurocircuitry (Vol. 3), cognition (Vol. 4), neurotherapeutics (Vol. 5), and epigenetics (Vol. 6). The seventh issue of Neuropsychopharmacology Reviews is devoted to biomolecular discovery and the implications for mechanisms, therapeutics, and biomarker development. The articles in this issue focus on the recent advances in the detection, subtyping, and monitoring of complex neural disease progression, the definition of new molecular targets for therapeutic intervention and biomarkers, with an emphasis on the use of genome-wide analytical technologies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
